000 01407 a2200421 4500
005 20250518040020.0
264 0 _c20200601
008 202006s 0 0 eng d
022 _a1464-410X
024 7 _a10.1111/bju.14800
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGnanapragasam, Vincent J
245 0 0 _aUsing prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.
_h[electronic resource]
260 _bBJU international
_c11 2019
300 _a758-767 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aPrognosis
650 0 4 _aProstatic Neoplasms
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aWatchful Waiting
700 1 _aBarrett, Tristan
700 1 _aThankapannair, Vineetha
700 1 _aThurtle, David
700 1 _aRubio-Briones, Jose
700 1 _aDomínguez-Escrig, Jose
700 1 _aBratt, Ola
700 1 _aStatin, Par
700 1 _aMuir, Kenneth
700 1 _aLophatananon, Artitaya
773 0 _tBJU international
_gvol. 124
_gno. 5
_gp. 758-767
856 4 0 _uhttps://doi.org/10.1111/bju.14800
_zAvailable from publisher's website
999 _c29665393
_d29665393